Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04519216 · ClinicalTrials.gov registry record · NA

Breastfeeding Education in the Time of COVID-19

A NA study of Breastfeeding and Breastfeeding, Exclusive, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT04519216 is a NA study of Breastfeeding and Breastfeeding, Exclusive that has completed, run by University of California, Davis. The registered enrollment target is 46 participants, below the 716-participant average among 28 other Breastfeeding trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04519216, a NA study of Breastfeeding and Breastfeeding, Exclusive, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

This project will establish that pediatric and family medicine residents who complete a hybrid breastfeeding medicine curriculum that includes an asynchronous unfolding case scenario along with telesimulation with a standardized patient (SP) will provide timely, skilled lactation support more frequently than residents randomized to an asynchronous unfolding case scenario followed by videoconference group discussion regarding care for the breastfeeding dyad.

Interventions

  • BEHAVIORAL Telesimulation

Study Locations (1)

California

  • University of California - Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2020-07-31
Est. Completion 2021-12-10
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04519216

The ClinicalTrials.gov registry entry for NCT04519216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 716-participant average among 28 other Breastfeeding trials with a reported enrollment target (94% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Breastfeeding appearing as the primary indexed condition, and to 1 intervention - of which Telesimulation is the first listed.

NCT04519216 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04519216 about?

NCT04519216 is a clinical study titled "Breastfeeding Education in the Time of COVID-19". This project will establish that pediatric and family medicine residents who complete a hybrid breastfeeding medicine curriculum that includes an asynchronous unfolding case scenario along with telesimulation with a standardized patient (SP) will provide timely, skilled lactation support more freque...

What is the current status of trial NCT04519216?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2020-07-31. Estimated completion is 2021-12-10.

What conditions does trial NCT04519216 study?

This clinical trial studies the following conditions: Breastfeeding, Breastfeeding, Exclusive, Educational Problems, Breastfeeding Jaundice.

What interventions are being tested in trial NCT04519216?

The interventions under investigation include: Telesimulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04519216?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04519216 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breastfeeding

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.